Sort Results:
List of Partnerships
Argenta and ANTABIO Announce Drug Discovery Collaboration |
|
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its... |
Partner:
ANTABIO |
Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial Drugs |
|
Broad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at... |
Partner:
Astra Zeneca |
Astra Zeneca and University of Pennsylvania Partner to Develop Treatments to Manage Obesity |
|
Astra Zeneca has entered into a research collaboration agreement with University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism to develop small and or large molecules to manage... |
Partner:
Astra Zeneca |
Bayer and UCSF Enter into a 10year Research & Development Partnership |
|
Bayer and University of California, San Francisco (UCSF) have signed a 10year master research and development agreement. The agreement provides a broad template for collaboration between the two... |
Partner:
Bayer |
Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes Space |
|
Sanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes.... |
Partner:
Sanofi |
California Institute for Quantitative Biosciences (QB3) |
|
QB3 isa tri-campus organization at UC Berkeley, UC San Francisco, and UC Santa Cruz. QB3 is the University of California’s hub for innovation and entrepreneurship in the life sciences. The... |
Partner:
Governor Davis |
CDRD |
|
Share resources for the discovery of new drugs stemming rom CDRD and IPS. |
Partner:
Center for Drug Research and Development |
CEO |
|
development of peptide therapeutics to metastatic cancer |
Partner:
Joyce A. Schroeder |
Cerecor Partners with Johns Hopkins Brain Science Institute to Treat Schizophrenia |
|
Cerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are... |
Partner:
Cerecor |
Creative BioMart |
|
|
Partner:
Creative BioMart |